AIMD
$1.46
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics.
Recent News
The E-Nose Knows: AI Learns to Smell
Among the possible implications are restoring a sense of smell and sniffing out potential health concerns.
Ainos initiates live AI Nose deployments within semi manufacturing
Ainos (AIMD) announced the start of AI Nose deployments tied to its first $2.1 million order from a semiconductor back-end customer, marking the Company’s transition from preparation into operation. During the second half of 2025, Ainos carried out deployment readiness preparations. This groundwork positioned the AI Nose platform for live environments. In January 2026, Ainos commenced on-site deployments associated with its initial $2.1 million order with a leading semiconductor packaging and te
BC-Most Active Stocks
Gibo Holdings Ltd. 139,986,518 0.0516
PCAOB fines PWR CPA for audit failures and reporting violations
The firm agreed to a $60,000 fine and committed to implement corrective measures before submitting any future PCAOB application.